Literature DB >> 9422805

Effects of oral administration of different doses of purified micronized flavonoid fraction on microvascular reactivity after ischaemia/reperfusion in the hamster cheek pouch.

E Bouskela1, F Z Cyrino, L Lerond.   

Abstract

1. The effects of a purified micronized flavonoid fraction (S5682) on mean internal diameter and blood flow of arterioles and venules, as well as the functional capillary density (FCD) were evaluated in the hamster cheek pouch microvasculature before and after 90 min of total ischaemia. 2. Male hamsters were treated for ten days, twice a day, with oral doses of S5682 (5, 20, 80 and 160 mg kg-1 day-1) or placebo (10% lactose solution). The cheek pouch preparation was placed under an intravital microscope coupled to a closed circuit TV system. Local ischaemia was obtained by a cuff mounted around the neck of the everted pouch where it leaves the mouth of the hamster. 3. Measurements were performed before ischaemia, at the onset of reperfusion and 10, 20, 30, 45 and 60 min thereafter. Diameters were measured by means of an image shearing device. Red blood cell (RBC) velocity was analysed by use of the dual-slit photometric technique. Blood flow was calculated from diameters and RBC velocities. FCD, defined as the number of capillaries with flowing blood per field of observation, was also assessed. 4. During reperfusion, placebo-treated animals showed a significant vasodilatation, a decrease in blood flow and FCD and S5682-treated animals showed a clear trend, dose-dependent, towards maintaining these parameters closer to the value found before ischaemia. 5. In conclusion, our results indicate that S5682 improves the microvascular reactivity and FCD after ischaemia/reperfusion. These data suggest that S5682 could function as an antioxidant, which may explain its beneficial therapeutic effect in chronic venous insufficiency where oxidative stress is involved in the pathological mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422805      PMCID: PMC1565111          DOI: 10.1038/sj.bjp.0701554

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

Review 1.  Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.

Authors:  Katherine A Lyseng-Williamson; Caroline M Perry
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Clinical nutrition in gerontology: chronic renal disorders of the dog and cat.

Authors:  A Pugliese; A Gruppillo; S Di Pietro
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

3.  The protective effect of diosmin on hepatic ischemia reperfusion injury: an experimental study.

Authors:  Yusuf Tanrikulu; Mefaret Sahin; Kemal Kismet; Sibel Serin Kilicoglu; Erdinc Devrim; Ceren Sen Tanrikulu; Esra Erdemli; Serap Erel; Kenan Bayraktar; Mehmet Ali Akkus
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

4.  Single Dose Oral and Intravenous Pharmacokinetics and Tissue Distribution of a Novel Hesperetin Derivative MTBH in Rats.

Authors:  Chenlin Shen; Zhengyue Qian; Ruonan Chen; Xiaoming Meng; Tingting Hu; Zhaolin Chen; Yangyang Li; Cheng Huang; Chaojie Hu; Jun Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

5.  Exploring the effect of Hesperetin-HSPC complex--a novel drug delivery system on the in vitro release, therapeutic efficacy and pharmacokinetics.

Authors:  Kuntal Maiti; Kakali Mukherjee; Venkatesh Murugan; Bishnu Pada Saha; Pulok Kumar Mukherjee
Journal:  AAPS PharmSciTech       Date:  2009-07-24       Impact factor: 3.246

6.  Effect of diosmin on apoptotic signaling molecules in N-nitrosodiethylamine-induced hepatocellular carcinoma in experimental rats.

Authors:  Srinivasan Perumal; Kulanthaivel Langeshwaran; Jayaraman Selvaraj; Rajagopal Ponnulakshmi; B Shyamaladevi; M P Balasubramanian
Journal:  Mol Cell Biochem       Date:  2018-02-26       Impact factor: 3.396

7.  Combination of Repurposed Drug Diosmin with Amoxicillin-Clavulanic acid Causes Synergistic Inhibition of Mycobacterial Growth.

Authors:  Anju Choorakottayil Pushkaran; Vivek Vinod; Muralidharan Vanuopadath; Sudarslal Sadasivan Nair; Shantikumar V Nair; Anil Kumar Vasudevan; Raja Biswas; Chethampadi Gopi Mohan
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

8.  Confirmation of diosmetin 3-O-glucuronide as major metabolite of diosmin in humans, using micro-liquid-chromatography-mass spectrometry and ion mobility mass spectrometry.

Authors:  Luigi Silvestro; Isabela Tarcomnicu; Constanta Dulea; Nageswara Rao B N Attili; Valentin Ciuca; Dan Peru; Simona Rizea Savu
Journal:  Anal Bioanal Chem       Date:  2013-08-16       Impact factor: 4.142

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.